Table 2.
All | Tigecycline Susceptible |
Tigecycline Non-Susceptible |
p | |
---|---|---|---|---|
n | 287 | 155 | 132 | |
Source | 0.5238 | |||
Urine | 175 (61) | 91 (59) | 84 (64) | |
Blood | 39 (14) | 26 (17) | 13 (10) | |
Wound | 33 (11) | 18 (11) | 15 (11) | |
Respiratory | 31 (11) | 16 (10) | 15 (11) | |
Other | 9 (3) | 4 (3) | 5 (4) | |
Infection | 127 (44) | 74 (48) | 53 (40) | 0.2332 |
Critically ill at time of culturea | 93 (32) | 54 (35) | 39 (30) | 0.3767 |
Patient location at time of culture | 0.3950 | |||
Ward | 119 (41) | 69 (45) | 50 (38) | |
Intensive care unit | 91 (32) | 49 (32) | 42 (32) | |
Emergency department | 77 (27) | 37 (24) | 40 (30) | |
Present on admissionb | 184 (64) | 89 (57) | 95 (72) | 0.0134 |
Hospital length of stay, days, median (IQR) | 10 (6–18) | 12 (7–23) | 8 (5–14) | 0.0015 |
All data in n (%), unless otherwise indicated.
as defined by Pitt bacteremia score≥4 on the day of first positive culture.
defined as a positive culture within within 48 hours of hospitalization. IQR: interquartile range